Regis (RGS) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
14 May, 2026Refinancing transaction overview
Completed refinancing on June 24, 2024, replacing the prior credit facility with a new $25 million revolving credit facility and a $105 million term loan due June 24, 2029.
Total outstanding debt reduced by over $80 million, from approximately $190 million to $105 million, lowering gross LTM leverage from about 7.9x to 4.4x.
Proceeds from the term loan fully refinanced the previous facility; the revolving credit facility is intended for general corporate purposes and is expected to remain largely undrawn.
The transaction extends debt maturity from August 2025 to June 2029 and is expected to generate significant cash interest savings.
Incremental liquidity secured to support long-term business strategy, with remaining OSP sale proceeds available for general use.
Key terms of the new credit facility
Facility includes a $25 million revolving credit facility (with a $10 million letter of credit sub-limit) and a $105 million term loan.
Interest rate is SOFR + 9.00%, with up to 4.50% payable in kind; rate steps down to SOFR + 8.50% if leverage falls below 3.75x.
First priority lien on all assets, with call protection and mandatory quarterly amortization (1.0% per annum for first 8 quarters, then 2.5%).
75% excess cash flow sweep with step-downs, and warrants for 15% of fully diluted equity at a $7.00 strike price.
Financial covenants include maximum leverage ratio, minimum fixed charge coverage ratio, maximum capital expenditures, and minimum liquidity.
Pro forma capitalization and liquidity
Pro forma total debt is $105 million, with $25 million revolving credit facility commitment and $9.3 million in outstanding letters of credit.
Estimated cash and cash equivalents of $9.0 million, resulting in total liquidity of $23.7 million.
Pro forma cash interest expense estimated at $10.9 million.
Net availability under the revolving credit facility expected to be about $15.7 million after accounting for letters of credit.
Total debt to March 2024 LTM Adjusted EBITDA is 4.4x.
Latest events from Regis
- Q3 2026 delivered higher same-store sales and profitability, led by operational gains and Alline acquisition.RGS
Q3 202613 May 2026 - Revenue up on Alline deal and company-owned growth; franchise revenue and net income down.RGS
Q2 20265 Feb 2026 - Profitability surged in 2024, fueled by debt refinancing and a $94.6M debt extinguishment gain.RGS
Q4 202423 Jan 2026 - Adjusted EBITDA margin rose to 40% as cost controls and digital initiatives offset revenue declines.RGS
Q1 202516 Jan 2026 - Alline acquisition and OSP proceeds drove net income and EBITDA growth despite revenue decline.RGS
Q2 202524 Dec 2025 - Strategic growth, leadership changes, and key governance proposals define this year's proxy.RGS
Proxy Filing1 Dec 2025 - Debt refinancing, board succession, and incentive plan updates drive renewed growth focus.RGS
Proxy Filing1 Dec 2025 - Shareholders to vote on board refresh, executive pay, auditor, stock plan, and tax benefits extension.RGS
Proxy Filing1 Dec 2025 - Board recommends all proposals, including director elections and Say-on-Pay, for virtual vote.RGS
Proxy Filing1 Dec 2025